Altice USA Inc (ATUS) concluded trading on Wednesday at a closing price of $2.90, with 4.2 million shares of worth about $12.19 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 57.61% during that period and on Wednesday the price saw a gain of about 2.47%. Currently the company’s common shares owned by public are about 278.98M shares, out of which, 232.36M shares are available for trading.
Stock saw a price change of 1.05% in past 5 days and over the past one month there was a price change of -1.02%. Year-to-date (YTD), ATUS shares are showing a performance of 20.33% which increased to 58.47% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.52 but also hit the highest price of $3.20 during that period. The average intraday trading volume for Altice USA Inc shares is 3.11 million. The stock is currently trading 2.73% above its 20-day simple moving average (SMA20), while that difference is up 7.69% for SMA50 and it goes to 24.74% higher than SMA200.
Altice USA Inc (NYSE: ATUS) currently have 278.98M outstanding shares and institutions hold larger chunk of about 53.21% of that.
The stock has a current market capitalization of $1.34B and its 3Y-monthly beta is at 1.59. It has posted earnings per share of -$0.22 in the same period. It has Quick Ratio of 0.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATUS, volatility over the week remained 4.77% while standing at 6.26% over the month.
Stock’s fiscal year EPS is expected to rise by 22.48% while it is estimated to increase by 55.04% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on February 18, 2025 offering an Outperform rating for the stock and assigned a target price of $3.50 to it. Coverage by UBS stated Altice USA Inc (ATUS) stock as a Neutral in their note to investors on August 02, 2024, suggesting a price target of $2 for the stock. On July 01, 2024, Goldman Initiated their recommendations, while on April 24, 2024, BofA Securities Resumed their ratings for the stock with a price target of $1.50. Stock get an Underweight rating from JP Morgan on April 11, 2024.
